PLASMID DNA EXPRESSING A SECRETED OR A NONSECRETED FORM OF HEPATITIS-C VIRUS NUCLEOCAPSID - COMPARATIVE-STUDIES OF ANTIBODY AND T-HELPER RESPONSES FOLLOWING GENETIC IMMUNIZATION
G. Inchauspe et al., PLASMID DNA EXPRESSING A SECRETED OR A NONSECRETED FORM OF HEPATITIS-C VIRUS NUCLEOCAPSID - COMPARATIVE-STUDIES OF ANTIBODY AND T-HELPER RESPONSES FOLLOWING GENETIC IMMUNIZATION, DNA and cell biology, 16(2), 1997, pp. 185-195
In a murine model, we have compared humoral and T-helper (Th) response
s induced following genetic immunization with two hepatitis C virus (H
CV) plasmid-derived immunogens: a plasmid expressing the full-length n
ucleocapsid (CAP) as a nonsecreted antigen (pCMVC2) and a plasmid expr
essing the amino-terminal part of CAP as a secreted antigen (pS2S,C2N)
. In BALB/c mice, intramuscular injection of either plasmid induced Ig
G(2a) antibodies associated with a Th1-like profile characterized by t
he in vitro splenic production of interleukin-2 (IL-2) and interferon-
gamma (IFN-gamma). The pS2S,C2N plasmid induced antibody titers three-
to fivefold higher than those obtained with the pCMVC2 plasmid (maxim
al titers 1:1,500 versus 1:500), In control experiments, immunization
using purified CAP antigen induced a predominant, but not exclusive, T
h2-like profile as determined by the splenic production of IL-4 and IL
-10, Six putative Th determinants were identified using a panoply of o
verlapping synthetic peptides in in vitro stimulation assays: amino ac
ids 20-44, 39-63, 79-113, 89-113, 118-142, and 138-152, For all CAP im
munogens, MHC haplotype of immunized mice was found to influence seroc
onversion rates but not the type of cytokines produced in vitro, H-2(d
) mice were faster responders and displayed recall T-cell activation b
y a larger number of peptides than H-2(b) mice, whereas H-2(s) mice we
re overall very poor responders, Splenic stimulation by at least one d
eterminant, amino acids 79-103, appeared to be highly specific of the
H-2(b) background and of DNA immunization only, These data indicate th
at DNA immunogens expressing different forms of HCV-CAP are not associ
ated with different Th profiles but rather different seroconversion ra
tes and antibody titers and that collaboration of distinct T-help epit
opes can be restricted by the MHC background.